Filing Details
- Accession Number:
- 0001437749-20-024489
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-25 21:41:41
- Reporting Period:
- 2020-11-24
- Accepted Time:
- 2020-11-25 21:41:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1158895 | Lemaitre Vascular Inc | LMAT | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1366346 | J Lawrence Jasinski | C/O Lemaitre Vascular, Inc. 63 Second Avenue Burlington MA 01803 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-11-24 | 5,000 | $31.30 | 13,333 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-11-24 | 2,500 | $23.56 | 15,833 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-11-24 | 7,500 | $39.50 | 8,333 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-11-24 | 5,000 | $0.00 | 5,000 | $31.30 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-11-24 | 2,500 | $0.00 | 2,500 | $23.56 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,500 | 2017-12-22 | 2022-12-22 | No | 4 | M | Direct |
5,000 | 2018-12-19 | 2023-12-19 | No | 4 | M | Direct |
Footnotes
- Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years.